By , (This Oct. 13 story corrects the headline and paragraphs 1 and 9 to show the federal government, not Eli Lilly, made the decision to pause a clinical trial of the company’s antibody drug)Lilly said earlier this month it was applying for emergency use authorization (EUA) for ...